nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—CYP1A1—Dacarbazine—sarcoma	0.144	0.203	CbGbCtD
Riluzole—ABCG2—Dactinomycin—sarcoma	0.135	0.191	CbGbCtD
Riluzole—ABCG2—Mitoxantrone—sarcoma	0.121	0.171	CbGbCtD
Riluzole—ABCG2—Vincristine—sarcoma	0.0831	0.118	CbGbCtD
Riluzole—ABCG2—Etoposide—sarcoma	0.0762	0.108	CbGbCtD
Riluzole—CYP1A2—Dacarbazine—sarcoma	0.0642	0.0909	CbGbCtD
Riluzole—ABCG2—Doxorubicin—sarcoma	0.0519	0.0736	CbGbCtD
Riluzole—CYP1A2—Etoposide—sarcoma	0.0314	0.0445	CbGbCtD
Riluzole—SLC7A11—forelimb zeugopod—sarcoma	0.0172	0.618	CbGeAlD
Riluzole—SLC7A11—smooth muscle tissue—sarcoma	0.00174	0.0626	CbGeAlD
Riluzole—SLC7A11—testis—sarcoma	0.00108	0.0389	CbGeAlD
Riluzole—SCN5A—cardiac atrium—sarcoma	0.000902	0.0325	CbGeAlD
Riluzole—ABCG2—myometrium—sarcoma	0.000757	0.0272	CbGeAlD
Riluzole—ABCG2—seminal vesicle—sarcoma	0.000683	0.0246	CbGeAlD
Riluzole—CYP1A2—hematopoietic system—sarcoma	0.000625	0.0225	CbGeAlD
Riluzole—CYP1A1—hematopoietic system—sarcoma	0.000617	0.0222	CbGeAlD
Riluzole—CYP1A1—skin of body—sarcoma	0.000536	0.0193	CbGeAlD
Riluzole—ABCG2—uterus—sarcoma	0.000491	0.0177	CbGeAlD
Riluzole—CYP1A1—cardiac atrium—sarcoma	0.000468	0.0169	CbGeAlD
Riluzole—CYP1A1—uterus—sarcoma	0.000466	0.0168	CbGeAlD
Riluzole—ABCG2—bone marrow—sarcoma	0.000416	0.015	CbGeAlD
Riluzole—ABCG2—testis—sarcoma	0.000356	0.0128	CbGeAlD
Riluzole—ABCG2—liver—sarcoma	0.000337	0.0121	CbGeAlD
Riluzole—CYP1A2—liver—sarcoma	0.000324	0.0117	CbGeAlD
Riluzole—CYP1A1—liver—sarcoma	0.000319	0.0115	CbGeAlD
Riluzole—ABCG2—lymph node—sarcoma	0.000258	0.00929	CbGeAlD
Riluzole—CYP1A1—lymph node—sarcoma	0.000245	0.00882	CbGeAlD
Riluzole—Somnolence—Etoposide—sarcoma	0.000156	0.000586	CcSEcCtD
Riluzole—Angina pectoris—Doxorubicin—sarcoma	0.000156	0.000585	CcSEcCtD
Riluzole—Hypersensitivity—Mitoxantrone—sarcoma	0.000155	0.000583	CcSEcCtD
Riluzole—Asthenia—Vincristine—sarcoma	0.000155	0.000583	CcSEcCtD
Riluzole—Vomiting—Thiotepa—sarcoma	0.000155	0.000583	CcSEcCtD
Riluzole—Pneumonia—Epirubicin—sarcoma	0.000155	0.000582	CcSEcCtD
Riluzole—Infestation NOS—Epirubicin—sarcoma	0.000154	0.000579	CcSEcCtD
Riluzole—Infestation—Epirubicin—sarcoma	0.000154	0.000579	CcSEcCtD
Riluzole—Vomiting—Dactinomycin—sarcoma	0.000154	0.000579	CcSEcCtD
Riluzole—Rash—Thiotepa—sarcoma	0.000154	0.000578	CcSEcCtD
Riluzole—Bronchitis—Doxorubicin—sarcoma	0.000154	0.000578	CcSEcCtD
Riluzole—Dermatitis—Thiotepa—sarcoma	0.000154	0.000578	CcSEcCtD
Riluzole—Headache—Thiotepa—sarcoma	0.000153	0.000574	CcSEcCtD
Riluzole—Rash—Dactinomycin—sarcoma	0.000153	0.000574	CcSEcCtD
Riluzole—Decreased appetite—Etoposide—sarcoma	0.000152	0.000573	CcSEcCtD
Riluzole—Pancytopenia—Doxorubicin—sarcoma	0.000152	0.000571	CcSEcCtD
Riluzole—Gastrointestinal disorder—Etoposide—sarcoma	0.000151	0.000569	CcSEcCtD
Riluzole—Asthenia—Mitoxantrone—sarcoma	0.000151	0.000568	CcSEcCtD
Riluzole—Fatigue—Etoposide—sarcoma	0.000151	0.000568	CcSEcCtD
Riluzole—Neuropathy peripheral—Epirubicin—sarcoma	0.000151	0.000568	CcSEcCtD
Riluzole—Stomatitis—Epirubicin—sarcoma	0.00015	0.000564	CcSEcCtD
Riluzole—Jaundice—Epirubicin—sarcoma	0.00015	0.000564	CcSEcCtD
Riluzole—Pain—Etoposide—sarcoma	0.00015	0.000563	CcSEcCtD
Riluzole—Constipation—Etoposide—sarcoma	0.00015	0.000563	CcSEcCtD
Riluzole—Urinary tract infection—Epirubicin—sarcoma	0.00015	0.000563	CcSEcCtD
Riluzole—Dysuria—Doxorubicin—sarcoma	0.000149	0.000562	CcSEcCtD
Riluzole—Neutropenia—Doxorubicin—sarcoma	0.000149	0.000562	CcSEcCtD
Riluzole—Diarrhoea—Vincristine—sarcoma	0.000148	0.000556	CcSEcCtD
Riluzole—Sweating—Epirubicin—sarcoma	0.000148	0.000555	CcSEcCtD
Riluzole—Pollakiuria—Doxorubicin—sarcoma	0.000148	0.000555	CcSEcCtD
Riluzole—Haematuria—Epirubicin—sarcoma	0.000147	0.000552	CcSEcCtD
Riluzole—Photosensitivity reaction—Doxorubicin—sarcoma	0.000146	0.000548	CcSEcCtD
Riluzole—Hepatobiliary disease—Epirubicin—sarcoma	0.000146	0.000548	CcSEcCtD
Riluzole—Weight increased—Doxorubicin—sarcoma	0.000145	0.000547	CcSEcCtD
Riluzole—Epistaxis—Epirubicin—sarcoma	0.000145	0.000546	CcSEcCtD
Riluzole—Nausea—Thiotepa—sarcoma	0.000145	0.000545	CcSEcCtD
Riluzole—Weight decreased—Doxorubicin—sarcoma	0.000145	0.000544	CcSEcCtD
Riluzole—Sinusitis—Epirubicin—sarcoma	0.000145	0.000543	CcSEcCtD
Riluzole—Feeling abnormal—Etoposide—sarcoma	0.000144	0.000543	CcSEcCtD
Riluzole—Diarrhoea—Mitoxantrone—sarcoma	0.000144	0.000542	CcSEcCtD
Riluzole—Nausea—Dactinomycin—sarcoma	0.000144	0.000541	CcSEcCtD
Riluzole—Agranulocytosis—Epirubicin—sarcoma	0.000144	0.00054	CcSEcCtD
Riluzole—Pneumonia—Doxorubicin—sarcoma	0.000143	0.000539	CcSEcCtD
Riluzole—Gastrointestinal pain—Etoposide—sarcoma	0.000143	0.000539	CcSEcCtD
Riluzole—Dizziness—Vincristine—sarcoma	0.000143	0.000538	CcSEcCtD
Riluzole—Infestation NOS—Doxorubicin—sarcoma	0.000143	0.000536	CcSEcCtD
Riluzole—Infestation—Doxorubicin—sarcoma	0.000143	0.000536	CcSEcCtD
Riluzole—Bradycardia—Epirubicin—sarcoma	0.000141	0.000529	CcSEcCtD
Riluzole—Neuropathy peripheral—Doxorubicin—sarcoma	0.00014	0.000525	CcSEcCtD
Riluzole—Urticaria—Etoposide—sarcoma	0.000139	0.000523	CcSEcCtD
Riluzole—Haemoglobin—Epirubicin—sarcoma	0.000139	0.000522	CcSEcCtD
Riluzole—Stomatitis—Doxorubicin—sarcoma	0.000139	0.000522	CcSEcCtD
Riluzole—Jaundice—Doxorubicin—sarcoma	0.000139	0.000522	CcSEcCtD
Riluzole—Rhinitis—Epirubicin—sarcoma	0.000139	0.000521	CcSEcCtD
Riluzole—Body temperature increased—Etoposide—sarcoma	0.000139	0.000521	CcSEcCtD
Riluzole—Abdominal pain—Etoposide—sarcoma	0.000139	0.000521	CcSEcCtD
Riluzole—Urinary tract infection—Doxorubicin—sarcoma	0.000139	0.000521	CcSEcCtD
Riluzole—Haemorrhage—Epirubicin—sarcoma	0.000138	0.00052	CcSEcCtD
Riluzole—Hepatitis—Epirubicin—sarcoma	0.000138	0.00052	CcSEcCtD
Riluzole—Hypoaesthesia—Epirubicin—sarcoma	0.000138	0.000517	CcSEcCtD
Riluzole—Vomiting—Vincristine—sarcoma	0.000138	0.000517	CcSEcCtD
Riluzole—Pharyngitis—Epirubicin—sarcoma	0.000137	0.000516	CcSEcCtD
Riluzole—Sweating—Doxorubicin—sarcoma	0.000137	0.000514	CcSEcCtD
Riluzole—Urinary tract disorder—Epirubicin—sarcoma	0.000137	0.000513	CcSEcCtD
Riluzole—Rash—Vincristine—sarcoma	0.000136	0.000513	CcSEcCtD
Riluzole—Dermatitis—Vincristine—sarcoma	0.000136	0.000512	CcSEcCtD
Riluzole—Oedema peripheral—Epirubicin—sarcoma	0.000136	0.000512	CcSEcCtD
Riluzole—Haematuria—Doxorubicin—sarcoma	0.000136	0.000511	CcSEcCtD
Riluzole—Connective tissue disorder—Epirubicin—sarcoma	0.000136	0.000511	CcSEcCtD
Riluzole—Urethral disorder—Epirubicin—sarcoma	0.000136	0.000509	CcSEcCtD
Riluzole—Headache—Vincristine—sarcoma	0.000136	0.000509	CcSEcCtD
Riluzole—Hepatobiliary disease—Doxorubicin—sarcoma	0.000135	0.000507	CcSEcCtD
Riluzole—Epistaxis—Doxorubicin—sarcoma	0.000134	0.000505	CcSEcCtD
Riluzole—Vomiting—Mitoxantrone—sarcoma	0.000134	0.000504	CcSEcCtD
Riluzole—Sinusitis—Doxorubicin—sarcoma	0.000134	0.000503	CcSEcCtD
Riluzole—Agranulocytosis—Doxorubicin—sarcoma	0.000133	0.0005	CcSEcCtD
Riluzole—Rash—Mitoxantrone—sarcoma	0.000133	0.000499	CcSEcCtD
Riluzole—Dermatitis—Mitoxantrone—sarcoma	0.000133	0.000499	CcSEcCtD
Riluzole—Headache—Mitoxantrone—sarcoma	0.000132	0.000496	CcSEcCtD
Riluzole—Erythema multiforme—Epirubicin—sarcoma	0.000131	0.000491	CcSEcCtD
Riluzole—Bradycardia—Doxorubicin—sarcoma	0.00013	0.00049	CcSEcCtD
Riluzole—Eye disorder—Epirubicin—sarcoma	0.000129	0.000486	CcSEcCtD
Riluzole—Hypersensitivity—Etoposide—sarcoma	0.000129	0.000485	CcSEcCtD
Riluzole—Haemoglobin—Doxorubicin—sarcoma	0.000129	0.000483	CcSEcCtD
Riluzole—Nausea—Vincristine—sarcoma	0.000129	0.000483	CcSEcCtD
Riluzole—Cardiac disorder—Epirubicin—sarcoma	0.000128	0.000482	CcSEcCtD
Riluzole—Rhinitis—Doxorubicin—sarcoma	0.000128	0.000482	CcSEcCtD
Riluzole—Haemorrhage—Doxorubicin—sarcoma	0.000128	0.000481	CcSEcCtD
Riluzole—Hepatitis—Doxorubicin—sarcoma	0.000128	0.000481	CcSEcCtD
Riluzole—Hypoaesthesia—Doxorubicin—sarcoma	0.000127	0.000478	CcSEcCtD
Riluzole—Pharyngitis—Doxorubicin—sarcoma	0.000127	0.000477	CcSEcCtD
Riluzole—Urinary tract disorder—Doxorubicin—sarcoma	0.000126	0.000475	CcSEcCtD
Riluzole—Oedema peripheral—Doxorubicin—sarcoma	0.000126	0.000474	CcSEcCtD
Riluzole—Asthenia—Etoposide—sarcoma	0.000126	0.000473	CcSEcCtD
Riluzole—Connective tissue disorder—Doxorubicin—sarcoma	0.000126	0.000473	CcSEcCtD
Riluzole—Angiopathy—Epirubicin—sarcoma	0.000125	0.000472	CcSEcCtD
Riluzole—Urethral disorder—Doxorubicin—sarcoma	0.000125	0.000471	CcSEcCtD
Riluzole—Nausea—Mitoxantrone—sarcoma	0.000125	0.00047	CcSEcCtD
Riluzole—Immune system disorder—Epirubicin—sarcoma	0.000125	0.000469	CcSEcCtD
Riluzole—Mediastinal disorder—Epirubicin—sarcoma	0.000125	0.000468	CcSEcCtD
Riluzole—Chills—Epirubicin—sarcoma	0.000124	0.000466	CcSEcCtD
Riluzole—Pruritus—Etoposide—sarcoma	0.000124	0.000466	CcSEcCtD
Riluzole—Arrhythmia—Epirubicin—sarcoma	0.000124	0.000464	CcSEcCtD
Riluzole—Alopecia—Epirubicin—sarcoma	0.000122	0.000459	CcSEcCtD
Riluzole—Mental disorder—Epirubicin—sarcoma	0.000121	0.000455	CcSEcCtD
Riluzole—Erythema multiforme—Doxorubicin—sarcoma	0.000121	0.000455	CcSEcCtD
Riluzole—Malnutrition—Epirubicin—sarcoma	0.00012	0.000452	CcSEcCtD
Riluzole—Diarrhoea—Etoposide—sarcoma	0.00012	0.000451	CcSEcCtD
Riluzole—Eye disorder—Doxorubicin—sarcoma	0.00012	0.000449	CcSEcCtD
Riluzole—Cardiac disorder—Doxorubicin—sarcoma	0.000119	0.000446	CcSEcCtD
Riluzole—Flatulence—Epirubicin—sarcoma	0.000119	0.000446	CcSEcCtD
Riluzole—Tension—Epirubicin—sarcoma	0.000118	0.000444	CcSEcCtD
Riluzole—Dysgeusia—Epirubicin—sarcoma	0.000118	0.000443	CcSEcCtD
Riluzole—Nervousness—Epirubicin—sarcoma	0.000117	0.000439	CcSEcCtD
Riluzole—Back pain—Epirubicin—sarcoma	0.000116	0.000438	CcSEcCtD
Riluzole—Angiopathy—Doxorubicin—sarcoma	0.000116	0.000436	CcSEcCtD
Riluzole—Dizziness—Etoposide—sarcoma	0.000116	0.000436	CcSEcCtD
Riluzole—Muscle spasms—Epirubicin—sarcoma	0.000116	0.000435	CcSEcCtD
Riluzole—Immune system disorder—Doxorubicin—sarcoma	0.000116	0.000434	CcSEcCtD
Riluzole—Mediastinal disorder—Doxorubicin—sarcoma	0.000115	0.000433	CcSEcCtD
Riluzole—Chills—Doxorubicin—sarcoma	0.000115	0.000431	CcSEcCtD
Riluzole—Arrhythmia—Doxorubicin—sarcoma	0.000114	0.00043	CcSEcCtD
Riluzole—Alopecia—Doxorubicin—sarcoma	0.000113	0.000425	CcSEcCtD
Riluzole—Mental disorder—Doxorubicin—sarcoma	0.000112	0.000421	CcSEcCtD
Riluzole—Ill-defined disorder—Epirubicin—sarcoma	0.000112	0.00042	CcSEcCtD
Riluzole—Vomiting—Etoposide—sarcoma	0.000111	0.000419	CcSEcCtD
Riluzole—Malnutrition—Doxorubicin—sarcoma	0.000111	0.000419	CcSEcCtD
Riluzole—Anaemia—Epirubicin—sarcoma	0.000111	0.000418	CcSEcCtD
Riluzole—Agitation—Epirubicin—sarcoma	0.000111	0.000416	CcSEcCtD
Riluzole—Rash—Etoposide—sarcoma	0.000111	0.000415	CcSEcCtD
Riluzole—Dermatitis—Etoposide—sarcoma	0.00011	0.000415	CcSEcCtD
Riluzole—Headache—Etoposide—sarcoma	0.00011	0.000413	CcSEcCtD
Riluzole—Flatulence—Doxorubicin—sarcoma	0.00011	0.000413	CcSEcCtD
Riluzole—Tension—Doxorubicin—sarcoma	0.000109	0.000411	CcSEcCtD
Riluzole—Dysgeusia—Doxorubicin—sarcoma	0.000109	0.00041	CcSEcCtD
Riluzole—Malaise—Epirubicin—sarcoma	0.000109	0.000408	CcSEcCtD
Riluzole—Nervousness—Doxorubicin—sarcoma	0.000108	0.000407	CcSEcCtD
Riluzole—Vertigo—Epirubicin—sarcoma	0.000108	0.000406	CcSEcCtD
Riluzole—Syncope—Epirubicin—sarcoma	0.000108	0.000406	CcSEcCtD
Riluzole—Leukopenia—Epirubicin—sarcoma	0.000108	0.000405	CcSEcCtD
Riluzole—Back pain—Doxorubicin—sarcoma	0.000108	0.000405	CcSEcCtD
Riluzole—Muscle spasms—Doxorubicin—sarcoma	0.000107	0.000402	CcSEcCtD
Riluzole—Palpitations—Epirubicin—sarcoma	0.000106	0.0004	CcSEcCtD
Riluzole—Loss of consciousness—Epirubicin—sarcoma	0.000106	0.000398	CcSEcCtD
Riluzole—Cough—Epirubicin—sarcoma	0.000105	0.000395	CcSEcCtD
Riluzole—Convulsion—Epirubicin—sarcoma	0.000104	0.000392	CcSEcCtD
Riluzole—Nausea—Etoposide—sarcoma	0.000104	0.000391	CcSEcCtD
Riluzole—Hypertension—Epirubicin—sarcoma	0.000104	0.000391	CcSEcCtD
Riluzole—Ill-defined disorder—Doxorubicin—sarcoma	0.000103	0.000388	CcSEcCtD
Riluzole—Anaemia—Doxorubicin—sarcoma	0.000103	0.000387	CcSEcCtD
Riluzole—Chest pain—Epirubicin—sarcoma	0.000102	0.000385	CcSEcCtD
Riluzole—Myalgia—Epirubicin—sarcoma	0.000102	0.000385	CcSEcCtD
Riluzole—Arthralgia—Epirubicin—sarcoma	0.000102	0.000385	CcSEcCtD
Riluzole—Agitation—Doxorubicin—sarcoma	0.000102	0.000385	CcSEcCtD
Riluzole—Anxiety—Epirubicin—sarcoma	0.000102	0.000384	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000102	0.000383	CcSEcCtD
Riluzole—Discomfort—Epirubicin—sarcoma	0.000101	0.000381	CcSEcCtD
Riluzole—Malaise—Doxorubicin—sarcoma	0.0001	0.000378	CcSEcCtD
Riluzole—Dry mouth—Epirubicin—sarcoma	0.0001	0.000377	CcSEcCtD
Riluzole—Vertigo—Doxorubicin—sarcoma	0.0001	0.000376	CcSEcCtD
Riluzole—Syncope—Doxorubicin—sarcoma	9.99e-05	0.000375	CcSEcCtD
Riluzole—Leukopenia—Doxorubicin—sarcoma	9.97e-05	0.000375	CcSEcCtD
Riluzole—Confusional state—Epirubicin—sarcoma	9.91e-05	0.000372	CcSEcCtD
Riluzole—Palpitations—Doxorubicin—sarcoma	9.84e-05	0.00037	CcSEcCtD
Riluzole—Oedema—Epirubicin—sarcoma	9.83e-05	0.000369	CcSEcCtD
Riluzole—Anaphylactic shock—Epirubicin—sarcoma	9.83e-05	0.000369	CcSEcCtD
Riluzole—Loss of consciousness—Doxorubicin—sarcoma	9.79e-05	0.000368	CcSEcCtD
Riluzole—Infection—Epirubicin—sarcoma	9.76e-05	0.000367	CcSEcCtD
Riluzole—Cough—Doxorubicin—sarcoma	9.72e-05	0.000365	CcSEcCtD
Riluzole—Shock—Epirubicin—sarcoma	9.67e-05	0.000363	CcSEcCtD
Riluzole—Convulsion—Doxorubicin—sarcoma	9.65e-05	0.000363	CcSEcCtD
Riluzole—Nervous system disorder—Epirubicin—sarcoma	9.64e-05	0.000362	CcSEcCtD
Riluzole—Thrombocytopenia—Epirubicin—sarcoma	9.62e-05	0.000362	CcSEcCtD
Riluzole—Hypertension—Doxorubicin—sarcoma	9.62e-05	0.000361	CcSEcCtD
Riluzole—Tachycardia—Epirubicin—sarcoma	9.59e-05	0.00036	CcSEcCtD
Riluzole—Skin disorder—Epirubicin—sarcoma	9.54e-05	0.000359	CcSEcCtD
Riluzole—Hyperhidrosis—Epirubicin—sarcoma	9.5e-05	0.000357	CcSEcCtD
Riluzole—Chest pain—Doxorubicin—sarcoma	9.48e-05	0.000356	CcSEcCtD
Riluzole—Myalgia—Doxorubicin—sarcoma	9.48e-05	0.000356	CcSEcCtD
Riluzole—Arthralgia—Doxorubicin—sarcoma	9.48e-05	0.000356	CcSEcCtD
Riluzole—Anxiety—Doxorubicin—sarcoma	9.45e-05	0.000355	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	9.42e-05	0.000354	CcSEcCtD
Riluzole—Discomfort—Doxorubicin—sarcoma	9.37e-05	0.000352	CcSEcCtD
Riluzole—Anorexia—Epirubicin—sarcoma	9.37e-05	0.000352	CcSEcCtD
Riluzole—Dry mouth—Doxorubicin—sarcoma	9.27e-05	0.000349	CcSEcCtD
Riluzole—Hypotension—Epirubicin—sarcoma	9.18e-05	0.000345	CcSEcCtD
Riluzole—Confusional state—Doxorubicin—sarcoma	9.17e-05	0.000344	CcSEcCtD
Riluzole—Anaphylactic shock—Doxorubicin—sarcoma	9.09e-05	0.000342	CcSEcCtD
Riluzole—Oedema—Doxorubicin—sarcoma	9.09e-05	0.000342	CcSEcCtD
Riluzole—Infection—Doxorubicin—sarcoma	9.03e-05	0.000339	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Epirubicin—sarcoma	8.95e-05	0.000336	CcSEcCtD
Riluzole—Shock—Doxorubicin—sarcoma	8.94e-05	0.000336	CcSEcCtD
Riluzole—Nervous system disorder—Doxorubicin—sarcoma	8.92e-05	0.000335	CcSEcCtD
Riluzole—Thrombocytopenia—Doxorubicin—sarcoma	8.9e-05	0.000335	CcSEcCtD
Riluzole—Insomnia—Epirubicin—sarcoma	8.89e-05	0.000334	CcSEcCtD
Riluzole—Tachycardia—Doxorubicin—sarcoma	8.87e-05	0.000333	CcSEcCtD
Riluzole—Skin disorder—Doxorubicin—sarcoma	8.83e-05	0.000332	CcSEcCtD
Riluzole—Paraesthesia—Epirubicin—sarcoma	8.82e-05	0.000332	CcSEcCtD
Riluzole—Hyperhidrosis—Doxorubicin—sarcoma	8.79e-05	0.00033	CcSEcCtD
Riluzole—Dyspnoea—Epirubicin—sarcoma	8.76e-05	0.000329	CcSEcCtD
Riluzole—Somnolence—Epirubicin—sarcoma	8.73e-05	0.000328	CcSEcCtD
Riluzole—Anorexia—Doxorubicin—sarcoma	8.67e-05	0.000326	CcSEcCtD
Riluzole—Dyspepsia—Epirubicin—sarcoma	8.65e-05	0.000325	CcSEcCtD
Riluzole—Decreased appetite—Epirubicin—sarcoma	8.54e-05	0.000321	CcSEcCtD
Riluzole—Hypotension—Doxorubicin—sarcoma	8.49e-05	0.000319	CcSEcCtD
Riluzole—Gastrointestinal disorder—Epirubicin—sarcoma	8.48e-05	0.000319	CcSEcCtD
Riluzole—Fatigue—Epirubicin—sarcoma	8.47e-05	0.000318	CcSEcCtD
Riluzole—Pain—Epirubicin—sarcoma	8.4e-05	0.000316	CcSEcCtD
Riluzole—Constipation—Epirubicin—sarcoma	8.4e-05	0.000316	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Doxorubicin—sarcoma	8.28e-05	0.000311	CcSEcCtD
Riluzole—Insomnia—Doxorubicin—sarcoma	8.22e-05	0.000309	CcSEcCtD
Riluzole—Paraesthesia—Doxorubicin—sarcoma	8.16e-05	0.000307	CcSEcCtD
Riluzole—Dyspnoea—Doxorubicin—sarcoma	8.1e-05	0.000305	CcSEcCtD
Riluzole—Feeling abnormal—Epirubicin—sarcoma	8.1e-05	0.000304	CcSEcCtD
Riluzole—Somnolence—Doxorubicin—sarcoma	8.08e-05	0.000304	CcSEcCtD
Riluzole—Gastrointestinal pain—Epirubicin—sarcoma	8.03e-05	0.000302	CcSEcCtD
Riluzole—Dyspepsia—Doxorubicin—sarcoma	8e-05	0.000301	CcSEcCtD
Riluzole—Decreased appetite—Doxorubicin—sarcoma	7.9e-05	0.000297	CcSEcCtD
Riluzole—Gastrointestinal disorder—Doxorubicin—sarcoma	7.85e-05	0.000295	CcSEcCtD
Riluzole—Fatigue—Doxorubicin—sarcoma	7.84e-05	0.000295	CcSEcCtD
Riluzole—Urticaria—Epirubicin—sarcoma	7.81e-05	0.000293	CcSEcCtD
Riluzole—Pain—Doxorubicin—sarcoma	7.77e-05	0.000292	CcSEcCtD
Riluzole—Constipation—Doxorubicin—sarcoma	7.77e-05	0.000292	CcSEcCtD
Riluzole—Body temperature increased—Epirubicin—sarcoma	7.77e-05	0.000292	CcSEcCtD
Riluzole—Abdominal pain—Epirubicin—sarcoma	7.77e-05	0.000292	CcSEcCtD
Riluzole—Feeling abnormal—Doxorubicin—sarcoma	7.49e-05	0.000282	CcSEcCtD
Riluzole—Gastrointestinal pain—Doxorubicin—sarcoma	7.43e-05	0.000279	CcSEcCtD
Riluzole—Hypersensitivity—Epirubicin—sarcoma	7.24e-05	0.000272	CcSEcCtD
Riluzole—Urticaria—Doxorubicin—sarcoma	7.22e-05	0.000271	CcSEcCtD
Riluzole—Abdominal pain—Doxorubicin—sarcoma	7.19e-05	0.00027	CcSEcCtD
Riluzole—Body temperature increased—Doxorubicin—sarcoma	7.19e-05	0.00027	CcSEcCtD
Riluzole—Asthenia—Epirubicin—sarcoma	7.05e-05	0.000265	CcSEcCtD
Riluzole—Pruritus—Epirubicin—sarcoma	6.95e-05	0.000261	CcSEcCtD
Riluzole—Diarrhoea—Epirubicin—sarcoma	6.72e-05	0.000253	CcSEcCtD
Riluzole—Hypersensitivity—Doxorubicin—sarcoma	6.7e-05	0.000252	CcSEcCtD
Riluzole—Asthenia—Doxorubicin—sarcoma	6.52e-05	0.000245	CcSEcCtD
Riluzole—Dizziness—Epirubicin—sarcoma	6.5e-05	0.000244	CcSEcCtD
Riluzole—Pruritus—Doxorubicin—sarcoma	6.43e-05	0.000242	CcSEcCtD
Riluzole—Vomiting—Epirubicin—sarcoma	6.25e-05	0.000235	CcSEcCtD
Riluzole—Diarrhoea—Doxorubicin—sarcoma	6.22e-05	0.000234	CcSEcCtD
Riluzole—Rash—Epirubicin—sarcoma	6.19e-05	0.000233	CcSEcCtD
Riluzole—Dermatitis—Epirubicin—sarcoma	6.19e-05	0.000233	CcSEcCtD
Riluzole—Headache—Epirubicin—sarcoma	6.16e-05	0.000231	CcSEcCtD
Riluzole—Dizziness—Doxorubicin—sarcoma	6.01e-05	0.000226	CcSEcCtD
Riluzole—Nausea—Epirubicin—sarcoma	5.84e-05	0.000219	CcSEcCtD
Riluzole—Vomiting—Doxorubicin—sarcoma	5.78e-05	0.000217	CcSEcCtD
Riluzole—Rash—Doxorubicin—sarcoma	5.73e-05	0.000215	CcSEcCtD
Riluzole—Dermatitis—Doxorubicin—sarcoma	5.73e-05	0.000215	CcSEcCtD
Riluzole—Headache—Doxorubicin—sarcoma	5.7e-05	0.000214	CcSEcCtD
Riluzole—Nausea—Doxorubicin—sarcoma	5.4e-05	0.000203	CcSEcCtD
